Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: An AGICC clinical trial

被引：0
|
作者：
Cohen, Deirdre J.
Goldberg, Judith D.
Leichman, Lawrence P.
Hochman, Tsivia
Newman, Elliot
Du, Kevin Lee
Megibow, Alec
Oberstein, Paul Eliezer
Al-Rajabi, Raed Moh'd Taiseer
Scott, Aaron J.
Bekaii-Saab, Tanios S.
Messersmith, Wells A.
Weekes, Colin D.
机构：
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[2] NYU, Grossman Sch Med, New York, NY USA
[3] NYU, Sch Med, New York, NY USA
[4] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA
[5] Northwell Hlth, New York, NY USA
[6] Yale Canc Ctr, New Haven, CT USA
[7] Univ Kansas, Med Ctr, Div Med Oncol, Kansas City, KS 66103 USA
[8] Univ Arizona, Tucson, AZ USA
[9] Mayo Clin, Comprehens Canc Ctr, Phoenix, AZ USA
[10] Univ Colorado, Aurora, CO USA
[11] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4175
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant therapy in resectable and borderline pancreatic adenocarcinomas
    Perez Casanova, L.
    Serrano, T.
    Fabregat, J.
    Valls, C.
    Laquente, B.
    Condom, E.
    VIRCHOWS ARCHIV, 2014, 465 : S311 - S311
  • [42] The role of systemic therapy in borderline resectable and locally advanced pancreatic ductal adenocarcinoma
    Lo, Victor C. K.
    Goodwin, Rachel A.
    Vickers, Michael M.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
  • [43] Borderline Resectable Pancreatic Cancer: Challenges for Clinical
    Fawaz, Ali
    Abdel-Rahman, Omar
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3589 - 3598
  • [44] Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?
    O'Reilly, Eileen M.
    Ferrone, Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (16) : 1757 - +
  • [45] Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma
    Xie, Hao
    Liu, Junjia
    Yin, Jun
    Ogden, John R.
    Mahipal, Amit
    McWilliams, Robert R.
    Truty, Mark J.
    Bekaii-Saab, Tanios S.
    Petersen, Gloria M.
    Jatoi, Aminah
    Hubbard, Joleen M.
    Ma, Wen Wee
    ONCOLOGIST, 2020, 25 (11): : E1681 - E1690
  • [46] Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Borhani, Amir A.
    Dewan, Rohit
    Furlan, Alessandro
    Seiser, Natalie
    Zureikat, Amer H.
    Singhi, Aatur D.
    Boone, Brian
    Bahary, Nathan
    Hogg, Melissa E.
    Lotze, Michael
    Zeh, Herbert J., III
    Tublin, Mitchell E.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 214 (02) : 362 - 369
  • [47] Long-term survival of patients receiving multimodality neoadjuvant therapy for resectable or borderline resectable pancreatic ductal adenocarcinoma
    McCormick, Kinsey
    Whiting, Samuel H.
    Gyurkey, Grace
    Koh, Wui-Jin
    Sinanan, Mika
    Coveler, Andrew L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [48] Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
    Ei, Shigenori
    Takahashi, Shinichiro
    Ogasawara, Toshihito
    Mashiko, Taro
    Masuoka, Yoshihito
    Nakagohri, Toshio
    GUT AND LIVER, 2023, 17 (05) : 698 - 710
  • [49] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [50] Predictors of Undergoing Surgical Resection after Neoadjuvant Chemoradiotherapy for Borderline Resectable and Resectable Pancreatic Adenocarcinoma
    Neibart, S. S.
    Mamidanna, S.
    Chundury, A.
    Sayan, M.
    Alexander, H. R.
    August, D.
    Berim, L. D.
    Boland, P. M.
    Grandhi, M. S.
    Gulhati, P.
    Kennedy, T. J.
    Langan, R. C.
    Spencer, K.
    Jabbour, S. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E63 - E64
12345